PTPRC and urinary bladder cancer: For the CD8+ T cells, we observed no significant difference in frequency in CD45+ cells among the different subtypes, but CD8+ T cells from GU, Uro, and control non-malignant bladder tissue (from patients not suffering from bladder cancer) were further compared using sequencing.